Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. SPRO
SPRO logo

SPRO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SPRO News

Spero Therapeutics and GSK Submit NDA for Tebipenem HBr, Triggering $25 Million Milestone Payment

Dec 19 2025Globenewswire

Spero Therapeutics and GSK Submit NDA for Tebipenem HBr, Triggering $25M Milestone Payment

Dec 19 2025Newsfilter

Spero Therapeutics Grants 90,000 RSUs to New Employee Under 2019 Inducement Plan

Nov 28 2025Globenewswire

Spero Therapeutics Grants 90,000 RSUs to New Employee Under 2019 Inducement Plan

Nov 28 2025Newsfilter

Most Active Stocks in Pre-Market on October 21, 2025: BYND, GSIT, SPRO, TSLL, IONZ, SQQQ, NIO, F, SMR, IONQ, GM, LAC

Oct 21 2025NASDAQ.COM

PIVOT-PO Phase 3 Results Highlight Tebipenem HBr as a Promising First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections (cUTIs)

Oct 21 2025Newsfilter

"ATA Creativity Global and Two Other Promising Low-Cost Stocks"

Sep 01 2025Yahoo Finance

AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer

Jul 04 2025NASDAQ.COM

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Jun 09 2025Benzinga

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

May 31 2025Benzinga

Pre-Market Most Active for May 30, 2025 : TSLL, BSLK, SQQQ, NVDA, TQQQ, IONQ, SPRO, LVWR, QBTS, BBAI, NIO, GAP

May 30 2025NASDAQ.COM

3 Penny Stocks to Watch Now, 5/29/25

May 29 2025TipRanks

What's Behind The Big Stock Moves? SPRO, TIL, IMAB....

May 28 2025NASDAQ.COM

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories

May 28 2025TipRanks

Crude Oil Gains 2%; Macy's Lowers Earnings Forecast

May 28 2025Benzinga

Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?

May 28 2025Benzinga